136 related articles for article (PubMed ID: 26813457)
1. Clinical significance of sCIP2A levels in breast cancer.
Xing ML; Lu YF; Wang DF; Zou XY; Zhang SX; Yun Z
Eur Rev Med Pharmacol Sci; 2016; 20(1):82-91. PubMed ID: 26813457
[TBL] [Abstract][Full Text] [Related]
2. CIP2A is associated with human breast cancer aggressivity.
Côme C; Laine A; Chanrion M; Edgren H; Mattila E; Liu X; Jonkers J; Ivaska J; Isola J; Darbon JM; Kallioniemi O; Thézenas S; Westermarck J
Clin Cancer Res; 2009 Aug; 15(16):5092-100. PubMed ID: 19671842
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
4. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF
Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells.
Liu CY; Hung MH; Wang DS; Chu PY; Su JC; Teng TH; Huang CT; Chao TT; Wang CY; Shiau CW; Tseng LM; Chen KF
Breast Cancer Res; 2014 Sep; 16(5):431. PubMed ID: 25228280
[TBL] [Abstract][Full Text] [Related]
6. Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer.
Chen W; Liang JL; Zhou K; Zeng QL; Ye JW; Huang MJ
Cell Commun Signal; 2020 Apr; 18(1):67. PubMed ID: 32321509
[TBL] [Abstract][Full Text] [Related]
7. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
Ren J; Li W; Yan L; Jiao W; Tian S; Li D; Tang Y; Gu G; Liu H; Xu Z
Br J Cancer; 2011 Dec; 105(12):1905-11. PubMed ID: 22075943
[TBL] [Abstract][Full Text] [Related]
8. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of CIP2A protein expression in breast cancer.
Yu G; Liu G; Dong J; Jin Y
Med Oncol; 2013 Jun; 30(2):524. PubMed ID: 23471718
[TBL] [Abstract][Full Text] [Related]
10. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
He H; Wu G; Li W; Cao Y; Liu Y
Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
[TBL] [Abstract][Full Text] [Related]
11. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
[TBL] [Abstract][Full Text] [Related]
12. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
13. p90/CIP2A mediates breast cancer cell proliferation and apoptosis.
Liu X; Peng B; Li Y; Lei N; Li W; Zhang JY
Mol Biol Rep; 2014 Nov; 41(11):7471-8. PubMed ID: 25086622
[TBL] [Abstract][Full Text] [Related]
14. CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of CIP2A in cutaneous malignant melanoma.
Shi F; Ding Y; Ju S; Wu X; Cao S
Biomarkers; 2014 Feb; 19(1):70-6. PubMed ID: 24369732
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of vasculogenic mimicry, PRRX1, and CIP2A in clear cell renal cell carcinoma and its clinicopathological significance.
Wang X; Yang R; Wang Q; Wang Y; Ci H; Wu S
Medicine (Baltimore); 2019 Sep; 98(36):e17028. PubMed ID: 31490389
[TBL] [Abstract][Full Text] [Related]
17. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A
J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954
[TBL] [Abstract][Full Text] [Related]
18. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells.
Chen XD; Tang SX; Zhang JH; Zhang LT; Wang YW
Oncol Rep; 2017 Aug; 38(2):1005-1012. PubMed ID: 28656258
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis.
Tang Q; Wang Q; Zeng G; Li Q; Jiang T; Zhang Z; Zheng W; Wang K
Oncol Rep; 2015 Nov; 34(5):2515-22. PubMed ID: 26327467
[TBL] [Abstract][Full Text] [Related]
20. Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein.
Liu J; Wang X; Zhou G; Wang H; Xiang L; Cheng Y; Liu W; Wang Y; Jia J; Zhao W
Gynecol Oncol; 2011 Aug; 122(2):430-6. PubMed ID: 21575984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
